Overall design |
6 groups of human jejunal crypts of obese subjects: 1) TAS2R43+, DMEM treatment (n=8), 2) TAS2R43+, 1 mM denatonium benzoate (DB) (n=7), 3) TAS2R43+, 30µM aloin (n=6), 4) TAS2R43-, DMEM treatment (n=5), 5) TAS2R43-, 1 mM DB (n=6), 6) TAS2R43-, 30 µM aloin (n=4) 3 groups of human jejunal crypts of lean subjects with a TAS2R43+ genotype: 1) DMEM treatment (n=4), 1 mM DB (n=4), 5) 30 µM aloin (n=4)
|